Fmr LLC Co Diagnostics, Inc. Transaction History

Fmr LLC

$1.6 Trillion
Q4 2024

A detailed history of Fmr LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Fmr LLC holds 218 shares of CODX stock, worth $78. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218

Holding current value

$78

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.7 - $1.36 $152 - $296	218 New	218 $0
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.5 $4 - $6	-4 Reduced 0.52%	761 $1,000
Q3 2023 Nov 13, 2023	BUY	$1.03 - $1.85 $3 - $5	3 Added 0.39%	765 $0
Q2 2023 Aug 11, 2023	SELL	$1.04 - $1.64 $5,636 - $8,888	-5,420 Reduced 87.67%	762 $0
Q1 2023 May 11, 2023	BUY	$1.39 - $3.24 $6,349 - $14,800	4,568 Added 283.02%	6,182 $9,000
Q4 2022 Feb 13, 2023	BUY	$2.32 - $3.68 $2,004 - $3,179	864 Added 115.2%	1,614 $4,000
Q1 2022 May 13, 2022	BUY	$5.03 - $9.61 $1,257 - $2,402	250 Added 50.0%	750 $5,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $1,356 - $1,731	-167 Reduced 25.04%	500 $4,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $2,610 - $3,971	349 Added 109.75%	667 $6,000
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $2,276 - $3,040	318 New	318 $2,000

Others Institutions Holding CODX

# of Institutions

Shares Held

5.59M

Call Options Held

67.5K

Put Options Held

174K

Vanguard Group Inc Valley Forge, PA

1.78M
Shares

$640,145
0.0% of portfolio
Private Advisory Group LLC Redmond, WA

1.18M
Shares

$425,387
0.1% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

556K
Shares

$200,023
0.0% of portfolio
Black Rock Inc. New York, NY

502K
Shares

$180,729
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

346K
Shares

$124,383
0.0% of portfolio

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.2M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account